Address: 127055, Россия, Москва, Улица Сущевская 21, офис 23
Tel: -6270
Web: http://www.imeda.ru/
IMEDA – IMEDA is a nonprofit organization that unites international manufacturers of medical equipment, devices and products in the Russian market.
Founded: 2005.
Structure of IMEDA:
• Committee on Public Relations and Media (PR-Committee)
• Committee on Development of Professional Staff (HR-Committee)
• Committee on coordination with health authorities and government organizations (Regulatory Committee).
Management of IMEDA:
• Alexandra Tretiakova, Executive Director of the Association
• Arman Voskerchyan Arman, Chairman of the Board of Directors of the Association, General Director Johnson & Johnson Russia and the CIS (Medical Devices Division)
• Igor Friedmann, Vice Chairman of the Board of Directors of the Association, General Director of Becton, Dickinson & Company (BD) Russia and the CIS
Documents developed by the Association:
• Code of Ethics of Manufacturers of Medical Devices (the ‘Code’) – 2008.
IMEDA Partners:
• Eucomed (European Medical Technology Association)
• GMTA (Global Health and Technology Alliance)
• Baker & McKenzie
• PWC
• Ernst & Young
• DT Global Business Consulting
• Frost & Sullivan
• EMAS (International group of companies, specializing in consulting and marketing research)
• Goltsblat BLP
Number of permanent members: 25 companies.
List of companies belonging to the association:
1. 3M
2. Abbott Laboratories
3. Alcon
4. Bausch & Lomb
5. Baxter
6. Beckman Coulter
7. Becton Dickinson
8. BioMerieux
9. Bio-Rad
10. Biotronik
11. ConvaTec
12. Covidien
13. Fresenius
14. GE
15. Johnson & Johnson
16. Karl Storz
17. Medtronic
18. Philips
19. Roche Diagnostics
20. SCA
21. Smith and Nephew
22. Synthes
23. Sysmex
24. Ursapharm
25. Zimmer
IMEDA was founded in 2005, and today counts amongst its members 28 leading international companies in the Russian medical technology sector. What are the main goals of the association today,…
You founded Euroservice, and have managed this business since its inception in 1996. What are the key drivers that have facilitated the growth of this company from a staff of…
In spring of 2010, Protek became the first Russian wholesaler to enter the public stock market, raising $400Mn in the biggest Russian IPO since 2007. You offered the IPO directly…
PAREXEL prides itself on improving the time schedule of a product launch. What is the significance of time-to-market in the healthcare industry, and how can PAREXEL expedite the process better…
Since our last report on Russia in 2007, there has been much emphasis placed on developing local industry, and reducing the nation’s reliance on imported pharmaceutical products. How do you…
You worked for ten years at Schering-Plough—one of the largest pharmaceutical companies in the world. In February of last year, you joined Merz Pharma, a much smaller player. Some may…
You have been at your current position for less than a year, and joined BIOCODEX after having managed the Russian affiliate of Yves Saint Laurent. You have a long history…
Russia and India have recently held a number of discussions regarding increased cooperation within the pharmaceutical sector. For example, the two nation’s health ministers have discussed decreasing administrative barriers to…
Biofund is an independent spin-off of the broader Russian Venture Capital organization. What is the working relationship and synergy between these agencies, and what are the market conditions that have…
Petrovax has always been an innovative company, making it quite unique in Russia where the domestic industry is predominantly comprised of generics manufacturers. How would you describe the positioning of…
After a long history in Philips, this is your first tenure as a regional CEO. Having been at this position for less than a year, what are your impressions of…
You were a Russian manager from 1996-2004, departed to Germany for some time, and recently made your way back to Russia in 2010. How has Russian healthcare and industry changed,…
You were responsible for merging Pierre Fabre’s activities in Russia in 2008, and heading the new legal entity and 100% subsidiary. What is it like to set up a new…
See our Cookie Privacy Policy Here
